Using sELISA, we detected similar levels of total tau (Tau5 capture antibody; Fig. 3E) in the PBS, Con, and AD-tau culture lysates (one-way ANOVA; F(2,15) = 0.2749, p = 0.3180), but significantly higher levels of PAD-exposed tau (TNT1 capture antibody; Fig. 3F; Kruskal-Wallis ANOVA with Dunn’s post hoc; H = 15.16, p < 0.0001; PBS vs. AD-tau p = 0.0003) and oligomeric tau (TOC1 capture antibody; Fig. 3G; Kruskal-Wallis ANOVA with Dunn’s post hoc; H = 11.66, p = 0.0003; PBS vs. AD-tau p = 0.0043; Con vs. AD-tau p = 0.0242) in the AD-tau culture lysates. The gene discussed is MAPT; the disease is Alzheimer disease.